Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate 3D-pQCT Study in Osteopenia
NCT00386360Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Apr 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in osteopenia comparing Risedronate with Placebo (2 arms). Primary endpoint: Trabecular Bone Volume to Tissue Volume at Distal Radius, Percent Change From Baseline at 12 months. Started Apr 2006; status: completed.
02
Drugs
risedronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00386360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386360.